Autoimmune Hepatitis

1. Evaluate the management of patients with end stage disease/hepatobiliary malignancies to facilitate local care of these patients.

2. Define indications and timing for referrals to a tertiary care liver center, leading to more effective utilization of the tertiary care center.

3. Create a community of learners and provide support and resources for the practitioners who manage end stage liver disease

ATTENDANCE / CREDIT
Upon completion of each End Stage Liver Disease TeleECHO session, a short survey will be sent to each participant.  Every 3 months, a longer survey will be used. The receipt of the completed survey is required prior to receiving your CME credit. Please send completed surveys to long.sydney@mayo.edu.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.